freak AH cnt. is more like it marie. Sold 4000 shaRES AND LOST A LOT OF MONEY. hE IS ONE BIG moron! lol! He whines like a girl. He needs to be castrated so he can squeal like a pig.. HMMM!
Sentiment: Strong Buy
Love the report this morning and the reaction as well, great activity and a PPS surge as well.
Just loaded up 800 *more* trading shares at 20.75. Should be a quick dump around 21.50. EASY money (well not that easy, I am currently saddled with trading shares at higher prices :-).
Everyone so jumpy...
You would not have made money short-term....
Maroons like White making stupid moves.....
Come back soon!
We be UP "BIG"!
Me too TGUNNS...I have to be very LONG... CUZ IM SOO DEEP in the RED...OTHERWISE- I MIGHT BE OUT NOW foe good...ON THE OTHER HAND--.IF I HAD an AVG of .0012 in LATF....id be buying MUCH the last 2 weeks.
GL, we need it !!! LOL
Trading has not been halted, called my brokerage firm and they said it traded 800 shares yesterday and again, no the trading has not been halted. Where did you get your info?
It is about criminals and corruption coming out ahead in the making of money. What is the long term advantage of that? Watch your back and your throat!
ERB consolidated 3 ERP systems into one, closed manufacturing facilities and businesses in England, Dallas and in the Wynwood Art District (now under contract to sell for $23M), and has new CEO, COO, Head of Sales all in the past year.
They have not announced a new CFO on par with the aforementioned recent senior management hires. However they will secure a new CFO as has been mentioned by ERB at the One Med Conference and is available online.
With all of the above ERB is late filing the annual report. Not necessarily a good excuse. But it explains it so there is no mystery or sinister conspiracy type of problem. While late filing is not a good thing, I am unclear on how investors believe it is anyway material. I am assuming they will file by May 15 as announced today. But it presents an opportunity.
I assume they will hire a new CFO as spoken about in January at One Med.... ERB is a public co and never to my knowledge lied to the public. They can get into trouble for that. Many companies do lie and or pump their stock with false promises and under delivery. That is one thing we cannot find fault with ERB. Straight shooters.
ERB is growing since Suresh from $15M to now $30M, adding $23M to the balance sheet with zero dilution. It will not show up in the numbers but they have spent the time and money to make acquisitions, new offices, hire people, consolidate systems, partner with largest distributors in the world, partner with ERB sister companies with plans to merge (as stated at One Med), opened new HQ to handle future growth, hired seasoned management capable of handling a Billion dollar company...
In January ERB guided they will grow into a $1 Billion co. by 2020. 4 years from now. Currently at $30M (or close to that) as we shall see May 15.
Do the math. Over 100% annual growth. At $1B in sales ERB is trading at a fraction of sales and maybe 1 or 2 PE. Current stock price weakness is a blessing for investors and an opportunity.
Disputes between China and Japan over sea boundaries are what led to the shortage of RE's coming from China and large price increase in 2011
The short position in this company continues to grow. We won't see exponential growth in sales until at least the third or fourth quarter, which is typical of start-ups without full coverage. It's why you see so many biotechs get clobbered shortly after approval when the price reflects all of the high expectations. You see it over and over again. Shorty banks on an uneven launch and scare tactics to run longs out of patience. You can sense it on this board right now. Baupost just keeps buying everyone's shares. You either have faith in the technology and product, or you don't. Mr. Market wants it to be as hard as possible for you to hold on and make money.
Sentiment: Strong Buy